WallStSmart
LXEO

Lexeo Therapeutics, Inc. Common Stock

NASDAQ: LXEO · HEALTHCARE · BIOTECHNOLOGY

$5.70
+0.26% today

Updated 2026-04-30

Market cap
$416.74M
P/E ratio
P/S ratio
478.26x
EPS (TTM)
$-1.86
Dividend yield
52W range
$2 – $11
Volume
0.9M

Lexeo Therapeutics, Inc. Common Stock (LXEO) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+54.5%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+72.3%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
+1.4%
Last 3 reports
Positive reaction rate
67%
2 of 3 quarters
Largest single-day move
+7.6%
2026-03-31
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-31$-0.27$5.27$5.67+7.6%
2026-03-16$-0.27+68.6%$6.66$6.38-4.2%
2025-11-05$-0.33+60.7%$8.35$8.42+0.8%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-03-31$-0.27
2025-12-31$-0.86$-0.27+68.6%
2025-09-30$-0.84$-0.33+60.7%
2025-06-30$-0.91$-0.60+34.1%
2025-03-31$-0.89$-0.99-11.2%
2024-12-31$-0.72$-0.78-8.3%$1.94M
2024-09-30$-0.72$-0.89-23.6%
2024-06-30$-0.77$-0.64+16.9%
2024-03-31$-0.77$-0.77+0.0%
2023-12-31$-0.73$-0.85-16.4%
2023-09-30$-2.60$-12.36-375.4%

Frequently asked questions

Has Lexeo Therapeutics, Inc. Common Stock beaten earnings estimates?
Lexeo Therapeutics, Inc. Common Stock has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +54.5% over the last 3 quarters.
How does LXEO stock react to earnings?
LXEO stock has moved an average of +1.4% in the trading day following earnings over its last 3 reports, with positive reactions in 67% of those quarters.